ArticleCancers2020

Ginsenoside Rp1, A Ginsenoside Derivative, Augments Anti-Cancer Effects of Actinomycin D via Downregulation of an AKT-SIRT1 Pathway.

Un-Jung Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.